Aptamer-mediated delivery of splice-switching oligonucleotides to the nuclei of cancer cells.
about
Oligonucleotide Therapies: The Past and the PresentAptamer-Mediated Targeted Delivery of Therapeutics: An UpdateNucleic Acid Aptamers as Potential Therapeutic and Diagnostic Agents for Lymphoma.Aptamer-conjugated Magnetic Nanoparticles as Targeted Magnetic Resonance Imaging Contrast Agent for Breast Cancer.Cell-type-specific, Aptamer-functionalized Agents for Targeted Disease TherapyTargeted disruption of β-arrestin 2-mediated signaling pathways by aptamer chimeras leads to inhibition of leukemic cell growth.Selective Targeting to Glioma with Nucleic Acid AptamersG-quartet oligonucleotide mediated delivery of proteins into photoreceptors and retinal pigment epithelium via intravitreal injection.Current progress on aptamer-targeted oligonucleotide therapeutics.Cellular uptake and intracellular trafficking of oligonucleotidesA high-throughput screening assay for the functional delivery of splice-switching oligonucleotides in human melanoma cells.Aptamers as Therapeutics.Aptamer-targeted DNA nanostructures for therapeutic deliveryConditional control of alternative splicing through light-triggered splice-switching oligonucleotides.AS1411 Aptamer-Anionic Linear Globular Dendrimer G2-Iohexol Selective Nano-Theranostics.The Bioactivity of D-/L-Isonucleoside- and 2'-Deoxyinosine-Incorporated Aptamer AS1411s Including DNA Replication/MicroRNA Expression.Modular cell-internalizing aptamer nanostructure enables targeted delivery of large functional RNAs in cancer cell lines.
P2860
Q27002403-EDFDA1E6-BCAB-424D-BDCC-449BD2951A40Q28066827-FA3DB0F7-46CD-4485-92AA-892230E9565AQ30434521-9B94B587-0B69-442E-9B13-F4B2E2AA339EQ31151661-958A3D7C-BD2A-4A04-A45E-0BB01217DA28Q33834772-9FDB3577-C77A-4F0E-BC03-C76481047C81Q35148896-6710A64A-CE5D-46DC-A710-E6A9C1F96105Q35740074-74C3ABA9-5986-45C7-BCC4-B2DC1ED483DDQ37677464-BF44E193-3AB9-4EE4-8705-700B533904B4Q38168595-2FBE2189-DDF1-41C9-8E74-261031D8DF32Q38424377-32E47D0F-624F-4EDE-AC45-8D74B8E76C6DQ38884283-404D83E4-559B-43B1-8F13-A2E7368BBBBFQ39070782-4C533381-B4D7-4526-90AC-50A6BFAD3F7FQ39513535-D093D191-E1E9-4C41-8479-0D8AFA56BDF3Q41264456-91E80A8E-A8EF-4A61-8BD9-5F6D95E5CA7BQ41717314-8A1D5085-334B-4A70-B59B-096170B1267BQ47105275-8580F6D2-02B0-46C8-AEA0-E601D86F25D5Q55378823-C02B09AF-8FA8-4F95-A50A-0B3ABD2F8D68
P2860
Aptamer-mediated delivery of splice-switching oligonucleotides to the nuclei of cancer cells.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh
2012年學術文章
@zh-hant
name
Aptamer-mediated delivery of s ...... to the nuclei of cancer cells.
@en
type
label
Aptamer-mediated delivery of s ...... to the nuclei of cancer cells.
@en
prefLabel
Aptamer-mediated delivery of s ...... to the nuclei of cancer cells.
@en
P2093
P2860
P356
P1476
Aptamer-mediated delivery of s ...... to the nuclei of cancer cells.
@en
P2093
Bruce A Sullenger
Elizabeth D Pratico
Jonathan W Kotula
Osamu Nakagawa
Rudolph L Juliano
P2860
P304
P356
10.1089/NAT.2012.0347
P577
2012-06-01T00:00:00Z